Boehringer Ingelheim Venture Fund — 2012 Investments

1 investments dated 2012 · listed companies and verified rows first · show all

ARMAGEN TECHNOLOGIES, INC.armagen.comNov 2012Acquired

Biotechnology company developing blood-brain-barrier-penetrating recombinant protein therapies for CNS disorders; acquired by JCR Pharmaceuticals in 2020.

Ruben Boado(Founder)in

Co-investorsMitsui Global Investment

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.